Skip to main content
    E

    eXoZymes, Inc. (EXOZ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.06
    -0.54 (-11.74%)

    Market Cap: $42.71M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 13
    		$-0.33N/AN/ABeat-17.9%
    Mar 26
    Reported May 14
    		$-0.28N/AN/ABeat-27.4%
    Dec 25
    Reported Mar 30
    		$-0.32N/AN/ABeat-31.8%
    Sep 25
    Reported Nov 13
    		$-0.27N/AN/ABeat-
    Jun 25
    Reported Aug 12
    		$-0.28N/AN/ABeat-
    Mar 25
    Reported May 12
    		$-0.22N/AN/ABeat-
    Dec 24
    Reported Mar 31
    		$-0.24N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-3.39EV/EBITDAN/A
    Price/FCF-4.92xFCF Yield-20.31%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-187.20%ROIC-276.06%
    Financial Health
    Debt/Equity0.01xInterest CoverageN/A
    Current Ratio3.81xQuick Ratio3.81x
    Trading Statistics
    BetaN/AAvg Volume9.16K
    52-Week High$18.4052-Week Low$4.35

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.12
    SMA 20$5.63
    SMA 50$6.09
    SMA 200$8.11
    EMA 10$5.00
    EMA 20$5.43
    EMA 50$5.97
    EMA 200$7.96

    MACD

    Line: -0.47Signal: -0.30Hist: -0.16

    ADX

    ADX: 23.4+DI: 17.4-DI: 28.9

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down100.0
    PSAR$5.59

    Bollinger Bands

    Upper Band$6.95
    Lower Band$4.30
    %B Position4709%(Upper)
    Band Width-0.09

    RSI (14-Day)

    Oversold
    19.0

    Momentum Oscillators

    Stoch %K6.2
    Stoch %D3.0
    Williams %R-87.4
    ROC (10d)-29.5%
    Momentum-1.70
    CCI (20d)-197.9
    MFI (14d)30.8

    Volatility Measures

    ATR (14d)$0.51(12.5%)
    StdDev (20d)0.66
    Hist Vol61.6%(High)

    Volume Flow

    VWAP$4.22
    OBV-313.8K
    AD Line-502.5K
    CMF (20d)-0.575

    Volume Metrics

    Avg Vol (20d)9.0K
    Vol Ratio2.7x(High)
    VWMA (20d)$5.44

    Pivot Points

    R3$5.05
    R2$4.93
    R1$4.76
    Pivot Point$4.64
    S1$4.47
    S2$4.35
    S3$4.18

    Advanced Oscillators

    TSI-38.10
    Ultimate Osc14.3
    KST-189.95

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$137,756$0$0$0$0$0
    Cost of Revenue$1.13M$830,724$1.11M$845,174$1.07M$613,924$860,026$546,095$731,607$390,044N/A$119,146
    Gross Profit$-1,127,667$-830,724$-1,107,820$-845,174$-1,068,838$-613,924$-860,026$-546,095$-731,607$-390,044N/A$-119,146
    Operating Expenses$1.83M$1.56M$1.59M$1.68M$1.48M$1.34M$1.12M$1.07M$596,997$618,414$985,047$272,700
    R&D$1.44M$1.12M$1.11M$1.22M$802,991$575,016$630,302$723,487$237,395$277,582$550,340$27,936
    SG&A$376,306$424,937$454,786$452,097$634,381$736,471$483,598$326,483$349,888$336,940$504,776$237,752
    Operating Income$-2,953,890$-2,386,974$-2,695,490$-2,522,208$-2,548,045$-1,950,728$-1,983,317$-1,611,726$-1,328,604$-1,008,458$-985,047$-391,846
    Interest Income$1,840$13,716$133,737$59,185$76,557$94,307$152,041$-44,647$-29,782$0$0$0
    Interest Expense$0$0$64,751$0$0$0$0$44,647$29,782$0$71,250$0
    Income Before Tax$-2,878,614$-2,370,247$-2,760,241$-2,286,991$-2,360,286$-1,856,421$-1,838,118$-1,656,373$-1,358,386$-1,008,458$-1,056,297$-520,596
    Income Tax Expense$0$0$-105,205$0$0$0$-2,144$0$2,144$0$42,267$0
    Net Income$-2,878,614$-2,370,247$-2,655,036$-2,286,991$-2,360,286$-1,856,421$-1,835,974$-1,656,373$-1,360,530$-1,008,458$-1,098,564$-520,596
    EBITDA$-2,815,495$-2,321,808$-2,634,591$-2,287,628$-2,378,290$-1,893,680$-1,929,205$-1,557,301$-1,273,737$-958,839$-997,331$-520,596
    EBIT$-2,880,453$-2,383,963$-2,695,490$-2,346,176$-2,436,843$-1,950,728$-1,983,317$-1,611,726$-1,328,604$-1,008,458$-1,056,297$-520,596
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about EXOZ

    EXOZ Valuation and Fair Value

    P/E
    -3.4x
    P/FCF
    -4.9x
    P/B
    9.6x
    See GNG's fair value

    EXOZ Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -276.1%
    ROE
    -187.2%
    FCF yield
    -20.3%

    EXOZ Competitors

    CompanyTicker
    Dogwood Therapeutics, Inc.DWTX
    Tevogen Bio Holdings Inc.TVGN
    Rapid Micro Biosystems IncRPID
    PureTech Health PLCPRTC
    Serina Therapeutics IncSER
    Ekso Bionics Holdings IncEKSO
    INmune Bio IncINMB
    Precipio IncPRPO

    Sector: Healthcare

    Frequently Asked Questions About EXOZ

    Does EXOZ pay dividends?

    eXoZymes, Inc. (EXOZ) does not currently pay a regular dividend.

    What is EXOZ's market cap?

    eXoZymes, Inc. (EXOZ) has a market capitalization of $42.71M with a current stock price of $4.06.

    Related stocks

    Sector: Healthcare

    All stocks starting with E

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In